Business Description
Founded in 2020 and headquartered in Beijing, Metis TechBio uses artificial intelligence to design and improve nanomaterials that deliver therapeutic agents into living organisms, serving drug makers, biotech firms, and medical research institutions in China and the United States. The company has built a connected set of tools that combines AI models, molecular simulations, and lab infrastructure to guide the creation and testing of these materials from early concept through to validation. Its work centers on making the development of complex drug delivery systems faster and more precise than traditional methods allow.
